94.05
price up icon2.83%   2.59
 
loading
Revvity Inc stock is traded at $94.05, with a volume of 1.29M. It is up +2.83% in the last 24 hours and up +12.82% over the past month. Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
See More
Previous Close:
$91.46
Open:
$92.09
24h Volume:
1.29M
Relative Volume:
1.01
Market Cap:
$10.92B
Revenue:
$2.77B
Net Income/Loss:
$286.61M
P/E Ratio:
40.02
EPS:
2.35
Net Cash Flow:
$524.11M
1W Performance:
+11.88%
1M Performance:
+12.82%
6M Performance:
-6.65%
1Y Performance:
-24.21%
1-Day Range:
Value
$91.56
$94.92
1-Week Range:
Value
$83.30
$94.92
52-Week Range:
Value
$81.36
$129.50

Revvity Inc Stock (RVTY) Company Profile

Name
Name
Revvity Inc
Name
Phone
781-663-6900
Name
Address
77 4TH AVENUE, WALTHAM
Name
Employee
11,000
Name
Twitter
Name
Next Earnings Date
2025-07-28
Name
Latest SEC Filings
Name
RVTY's Discussions on Twitter

Compare RVTY with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
RVTY
Revvity Inc
94.05 10.62B 2.77B 286.61M 524.11M 2.35
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
543.32 198.23B 43.21B 6.58B 6.17B 17.28
Diagnostics & Research icon
DHR
Danaher Corp
214.99 150.61B 24.01B 3.41B 4.86B 4.7082
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
631.19 50.71B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
141.64 39.32B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
206.63 34.74B 15.70B 1.24B 2.01B 6.9036

Revvity Inc Stock (RVTY) Upgrades & Downgrades

Date Action Analyst Rating Change
May-01-25 Upgrade UBS Neutral → Buy
Jan-10-25 Downgrade Bernstein Outperform → Mkt Perform
Dec-13-24 Upgrade BofA Securities Neutral → Buy
Oct-15-24 Upgrade Barclays Equal Weight → Overweight
Aug-28-24 Initiated Wells Fargo Equal Weight
Jul-08-24 Initiated Leerink Partners Outperform
Jun-03-24 Resumed Jefferies Hold
Jan-16-24 Downgrade UBS Buy → Neutral
Jan-04-24 Upgrade Evercore ISI In-line → Outperform
Dec-19-23 Initiated Wells Fargo Equal Weight
Dec-13-23 Initiated Wolfe Research Peer Perform
Sep-28-23 Initiated Bernstein Outperform
Jul-19-23 Initiated Raymond James Outperform
May-23-23 Resumed Goldman Buy
View All

Revvity Inc Stock (RVTY) Latest News

pulisher
Oct 03, 2025

Using AI based signals to follow Revvity Inc.Weekly Trade Analysis & Technical Buy Zone Confirmations - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Can a trend reversal in Revvity Inc. lead to recoveryQuarterly Portfolio Report & Advanced Swing Trade Entry Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Revvity to develop type 1 diabetes early detection assay with Sanofi - Investing.com Nigeria

Oct 03, 2025
pulisher
Oct 03, 2025

Chart based analysis of Revvity Inc. trendsJuly 2025 Levels & Weekly High Conviction Ideas - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Is Revvity Inc. stock undervalued vs historical averagesLong Setup & Accurate Entry/Exit Alerts - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Revvity Inc. stock trend outlook and recovery path2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Is Revvity Inc. stock a top pick for value investorsGlobal Markets & Weekly Momentum Stock Picks - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Automated trading signals detected on Revvity Inc.Trade Signal Summary & Safe Entry Trade Signal Reports - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Order flow analysis tools used on Revvity Inc.July 2025 WrapUp & Weekly Setup with ROI Potential - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Will Revvity Inc. (PKN) stock enhance shareholder valueDay Trade & Expert Approved Trade Ideas - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Lucem, Revvity partner with Sanofi for early T1D detection - BioWorld MedTech

Oct 02, 2025
pulisher
Oct 02, 2025

Barclays Adjusts Revvity (RVTY) Price Target, Maintains Overweig - GuruFocus

Oct 02, 2025
pulisher
Oct 02, 2025

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes - PharmiWeb.com

Oct 02, 2025
pulisher
Oct 02, 2025

Barclays Maintains Revvity (RVTY) Overweight Recommendation - Nasdaq

Oct 02, 2025
pulisher
Oct 02, 2025

Revvity Expands Type 1 Diabetes Program With Sanofi Support - Nasdaq

Oct 02, 2025
pulisher
Oct 02, 2025

Sanofi (SNY) Supports Revvity's Expansion in Type 1 Diabetes Ass - GuruFocus

Oct 02, 2025
pulisher
Oct 02, 2025

Revvity Launches Program to Expand Type 1 Diabetes Diagnosis Offering - MarketScreener

Oct 02, 2025
pulisher
Oct 02, 2025

Barclays Adjusts Price Target on Revvity to $100 From $110, Maintains Overweight Rating - MarketScreener

Oct 02, 2025
pulisher
Oct 01, 2025

How Revvity Inc. (PKN) stock reacts to Fed tighteningJuly 2025 Breakouts & Free Reliable Trade Execution Plans - newser.com

Oct 01, 2025
pulisher
Oct 01, 2025

Will Revvity Inc. stock sustain high P E ratiosJuly 2025 PostEarnings & Daily Price Action Insights - newser.com

Oct 01, 2025
pulisher
Sep 30, 2025

Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know - The Globe and Mail

Sep 30, 2025
pulisher
Sep 30, 2025

Revvity Launches AI Software Transforming Preclinical Imaging - Precedence Research

Sep 30, 2025
pulisher
Sep 30, 2025

How to recover losses in Revvity Inc. stockRate Cut & High Conviction Buy Zone Alerts - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis - MarketScreener

Sep 29, 2025
pulisher
Sep 29, 2025

Revvity (RVTY) Unveils Advanced AI Imaging Software for Researchers - GuruFocus

Sep 29, 2025
pulisher
Sep 29, 2025

Revvity launches AI-powered multimodal analysis software for imaging research By Investing.com - Investing.com South Africa

Sep 29, 2025
pulisher
Sep 29, 2025

Revvity launches AI-powered multimodal analysis software for imaging research - Investing.com

Sep 29, 2025
pulisher
Sep 29, 2025

Revvity, Inc. Unveils New AI Software Offering to Transform Preclinical Imaging Analysis - MarketScreener

Sep 29, 2025
pulisher
Sep 29, 2025

Should You Think About Buying Revvity, Inc. (NYSE:RVTY) Now? - Yahoo Finance

Sep 29, 2025
pulisher
Sep 29, 2025

Revvity Inc PKN Stock Analysis and ForecastMarket Sentiment Shifts & Affordable Portfolio Trading - earlytimes.in

Sep 29, 2025
pulisher
Sep 29, 2025

Is Revvity Inc PKN a good long term investmentDouble Top/Bottom Patterns & High Return Portfolio Growth - earlytimes.in

Sep 29, 2025
pulisher
Sep 28, 2025

What analysts say about Revvity Inc stockGlobal Trade Effects & Affordable Trading Strategies - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

Published on: 2025-09-27 18:11:56 - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

Does AI Enzyme Partnership Mark a Turning Point for Revvity’s (RVTY) Clinical Growth Ambitions? - Sahm

Sep 27, 2025
pulisher
Sep 27, 2025

What drives Revvity Inc PKN stock priceInstitutional Holding Changes & Small Budget Trading Portfolio - earlytimes.in

Sep 27, 2025
pulisher
Sep 26, 2025

Revvity Stock: Is RVTY Underperforming the Healthcare Sector? - MSN

Sep 26, 2025
pulisher
Sep 23, 2025

Revvity (RVTY) Receives a Buy from Bank of America Securities - The Globe and Mail

Sep 23, 2025
pulisher
Sep 23, 2025

Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Sys - PharmiWeb.com

Sep 23, 2025

Revvity Inc Stock (RVTY) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research WAT
$328.39
price up icon 2.01%
diagnostics_research DGX
$179.33
price down icon 0.90%
$167.35
price up icon 4.46%
diagnostics_research LH
$276.94
price down icon 0.89%
diagnostics_research MTD
$1,314.04
price up icon 1.04%
diagnostics_research IQV
$206.63
price up icon 1.12%
Cap:     |  Volume (24h):